Seizure (journal)

From WikiMD's Medical Encyclopedia

Revision as of 01:12, 20 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Seizure is a peer-reviewed medical journal that covers research in the field of epilepsy. The journal was established in 1992 and is published by Elsevier. The editor-in-chief is currently Mark Cook (University of Melbourne). The journal is abstracted and indexed in PubMed, Scopus, and the Science Citation Index. According to the Journal Citation Reports, the journal has a 2019 impact factor of 2.798.

History[edit]

The journal was established in 1992. It is published by Elsevier, a global information analytics business specializing in science and health.

Scope[edit]

The journal covers research in the field of epilepsy, a neurological disorder marked by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, associated with abnormal electrical activity in the brain.

Editor-in-chief[edit]

The current editor-in-chief is Mark Cook, a professor at the University of Melbourne. He is a recognized expert in the field of epilepsy.

Abstracting and indexing[edit]

The journal is abstracted and indexed in several databases including PubMed, Scopus, and the Science Citation Index. These databases allow researchers to easily find and access the articles published in the journal.

Impact factor[edit]

According to the Journal Citation Reports, the journal has a 2019 impact factor of 2.798. The impact factor is a measure of the yearly average number of citations to recent articles published in that journal.

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.